The 37 analysts offering 12-month price forecasts for Dr Reddy's Laboratories Ltd have a median target of 67.27, with a high estimate of 78.32 and a low estimate of 45.32. The median estimate represents a -3.44% decrease from the last price of 69.66.
The current consensus among 38 polled investment analysts is to Buy stock in Dr Reddy's Laboratories Ltd. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.68
Reporting Date Jan 26
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.